The role of ACEI/ARBS in reducing morbidity in non- diabetic patients with an ischemic heart disease with left ventricular ejection fraction >= 50. At North state, Sudan. From October 2026 to January 2027.
القسم الأول: معلومات الباحث / Principal Investigator Information
القسم الثاني: تفاصيل الدراسة البحثية / Research Study Details
القسم الثالث: الجوانب الأخلاقية / Ethical Considerations
القسم الرابع: قائمة المرفقات المطلوبة / Required Attachments
القسم الخامس: الإقرار والتوقيع / Acknowledgment and Signature
معلومات الباحث / Researcher Information
DALAL NOURELDIN FADLELMULA MOHAMEDELAMIN
dalal.nooreldein@gmail.com
00249910004033
مستشفى دنقلا التخصصي و مركز الجميح لامراض السكري
اسم المؤسسة التي سيتم فيها عمل البحث / Name of the institution where the research will be conducted
دنقلا.الولاية الشمالية
معلومات الدراسة / Study Information
أبحاث طبية / Medical Research
messages.degree_medical_research - messages.degree_medical_research
21,000.00 SDG
To study the role of ACEI/ARBS in reducing morbidity in non- diabetic patients with an ischemic heart disease with left ventricular ejection fraction>= 50 and, to correlate between its use and outcomes and, affecting factors on the outcome
Oct 19, 2026 - Feb 11, 2027
Nov 01, 2026 - Jan 31, 2027
الاعتبارات الأخلاقية / Ethical Considerations
Written
Private data of the patients will be kept confidential by using serial number from the questionnaire data and reporting only the required information and preserving files.
No potential risk
Participant had the right to benefit from the researcher knowledge and skills (by informing the head of the department by the missed important information from the files).